Study Of Investigational Regimen Combining FDA Approved HIV Drugs In HIV Subjects Experiencing Early Virologic Failure - Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00038506

Locations


United States, California
	GSK Investigational Site
	Los Angeles, California, United States, 90027
	GSK Investigational Site
	San Rafael, California, United States, 94903

United States, Florida
	GSK Investigational Site
	Miami Beach, Florida, United States, 33139
	GSK Investigational Site
	Fort Lauderdale, Florida, United States, 33145
	GSK Investigational Site
	Tallahassee, Florida, United States, 32303
	GSK Investigational Site
	Jacksonville, Florida, United States, 32206
	GSK Investigational Site
	North Miami, Florida, United States, 33161
	GSK Investigational Site
	Miami, Florida, United States, 33136
	GSK Investigational Site
	Lake Worth, Florida, United States, 33463
	GSK Investigational Site
	Orlando, Florida, United States, 32804

United States, Georgia
	GSK Investigational Site
	Decatur, Georgia, United States, 30033
	GSK Investigational Site
	Atlanta, Georgia, United States, 30309

United States, Illinois
	GSK Investigational Site
	Chicago, Illinois, United States, 60657
	GSK Investigational Site
	Maywood, Illinois, United States, 60153

United States, Indiana
	GSK Investigational Site
	Lafayette, Indiana, United States, 47904

United States, Michigan
	GSK Investigational Site
	Berkeley, Michigan, United States, 48072

United States, New York
	GSK Investigational Site
	Valhalla, New York, United States, 10595
	GSK Investigational Site
	Bronx, New York, United States, 10461
	GSK Investigational Site
	New York, New York, United States, 10014

United States, Oklahoma
	GSK Investigational Site
	Tulsa, Oklahoma, United States, 74114

United States, Texas
	GSK Investigational Site
	Arlington, Texas, United States, 76015
	GSK Investigational Site
	Dallas, Texas, United States, 75246
	GSK Investigational Site
	Dallas, Texas, United States, 75216
	GSK Investigational Site
	Houston, Texas, United States, 77004
	GSK Investigational Site
	Dallas, Texas, United States, 75208

United States, Washington
	GSK Investigational Site
	Seattle, Washington, United States, 98104

United States, Wisconsin
	GSK Investigational Site
	Green Bay, Wisconsin, United States, 54301

Sponsors and Collaborators

GlaxoSmithKline

Investigators


Study Director:	GSK Clinical Trials, MD	GlaxoSmithKline